NANOG and Hyperglycemia: Western blotting revealed that hyperglycemia-suppressed CHIP induces p53 expression, resulting in the loss of self-renewal factors, such as Sox2, Oct4, and Nanog, in a dose-dependent manner (Fig. 1A-B).